New research characterises effectiveness and variability in patient recruitment and retention practices

Although the managers of nine out of 10 clinical trials worldwide meet their patient enrolment goals, reaching those targets typically means that drug developers need to nearly double their original timelines, according to new research from the Tufts Center for the Study of Drug Development (CSDD) that benchmarks patient recruitment and retention practices. Read more here.